Adc Therapeutics SA (ADCT) Financials

$1.34

$-0.02 (-1.47%)

As on 08-Sep-2026 14:40EDT

Market cap

$169 Mln

Revenue (TTM)

$79 Mln

P/E Ratio

--

P/B Ratio

3.4

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20
Cash From Operating Activities	--	-141.17	-123.84	-118.69	-118.69	-136.79
Cash Flow from Investing Activities	--	0.40	-0.87	-3.22	--	-2.51
Cash from Financing Activities	--	150.95	97.05	73.88	73.88	-0.59
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20
Adjusted EPS ($)	-0.66	-0.95	-1.50	-2.92	-2.92	-1.95
Cash EPS ($)	--	-0.94	-1.47	-2.88	-2.88	-1.92
Adjusted Book Value ($)	--	--	--	--	--	0.99
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.94	-1.17	-1.44	-1.44	-1.70
Free Cash Flow per Share ($)	--	-0.94	-1.18	-1.48	-1.48	-1.70

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20
ROCE (%)	--	-164.38	304.97	1,005.58	-263.46	-75.65
ROE (%)	--	73.43	89.97	161.93	806.60	-186.86
ROA (%)	-20.90	-44.22	-46.65	-67.66	-54.31	-30.81
EBIT Margin (%)	-53.31	-112.03	-149.53	-214.34	-214.27	-52.44
Net Margin (%)	-123.03	-175.31	-222.83	-345.11	-345.11	-74.86
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20
Revenue Growth (%)	1.97	0.15	0.02	-0.67	-0.67	5.19
EBIT Growth (%)	64.72	13.95	28.95	-35.43	-20.56	52.79
Net Profit Growth (%)	42.98	9.64	34.25	-52.78	-54.08	31.69
EPS Growth (%)	57.71	0.37	0.49	-0.50	-0.47	0.35
Book Value Growth (%)	15.93	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20
Price / Earnings	--	-3.72	-1.33	-0.57	-0.31	-1.97
Price / Book Value	3.42	-2.86	-1.04	-0.92	-0.50	3.90
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.43	-7.93	-0.80	0.12	0.55	-1.05
Close Price ($)	1.07	3.53	1.99	1.66	0.90	3.84
High Price ($)	4.98	4.80	6.04	5.75	5.75	21.27
Low Price ($)	0.78	1.05	1.45	0.36	0.68	2.69
Market Cap ($ Cr)	168.52	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20
Debt to Equity	--	-2.36	-0.61	-0.84	-0.84	1.63
Short term debt to equity ratio	-0.03	-0.02	-0.01	-0.01	-0.01	0.17
Current Ratio	3.03	4.37	3.82	4.97	4.97	5.31
Quick Ratio	2.97	4.31	3.59	4.73	4.73	5.16
Interest Coverage	-0.86	-1.77	-2.11	-3.22	-3.22	-3.00

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Sep-23	Dec-22	Sep-22	Dec-21	Sep-21	Dec-20	Sep-20
Debtors to sales (%)	35.59	35.79	28.68	36.20	36.20	34.76
Asset Turnover	0.17	0.25	0.21	0.20	0.16	0.41
Receivable days	--	110.96	117.30	132.23	270.15	131.10
Inventory Days	--	537.14	1,061.06	2,336.36	2,508.73	1,694.97
Payable days	--	647.40	1,031.41	2,248.55	2,016.17	1,366.62
Cash Conversion Cycle	--	0.71	146.95	220.04	762.71	459.45

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.